Mark LaBarge studied genetics at the University of California, Davis, and then earned his PhD in molecular pharmacology at Stanford University in 2004. He is currently professor at the Department of Population Sciences, City of Hope National Cancer Center, California.
Mark LaBarge is author on 30 articles in peerreviewed journals and 6 book chapters that mainly address the biology of the microenvironment and stem cells in the breast, and is currently on the editorial board of the Frontiers in Cell and Developmental Biology (associate editor) and the Journal of Breast Cancer Survival. He is also grant reviewer for NIH, NSF, US Department of Defense, the European Research Council, Human Frontiers, Breast Cancer Campaign UK and other international organizations. He has received several awards, among them the US National Institute of Health Pathway to Independence Award, and the Era of Hope Scholar Award (CDMRP Breast Cancer Research Program).
Professor LaBarge’s principle interests are to understand the role of microenvironment in mammary stem cell fate decisions in the context of aging and breast cancer. The objective of his research is to generate a comprehensive understanding of the effects of aging on the human mammary gland and how the resulting processes may contribute to tumorigenesis. His team is actively engaged in developing strategies to delay the biological effects of aging in the breast as a means of cancer prevention.